Norbert Kraut, Senior Executive Scientist at Boehringer Ingelheim, shared a post by Cancer Discovery on X, adding:
“Excited to share work from the AACR Lung Cancer Task Force in Cancer Discovery, coinciding with AACR26 Lung cancer remains the leading cause of global cancer-related deaths.
Here, we describe areas of unmet need and define near-term research priorities and opportunities to reduce lung cancer morbidity and mortality It’s a great pleasure to work with all colleagues in the AACR Lung Team.”
Quoting Cancer Discovery’s post:
“Online now for AACR26 by the AACR Lung Cancer Task Force – A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention and Interception”
Title: A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention and Interception
Authors: Monte M. Winslow, Mohamed A. Ahmed, Christine D. Berg, James R.M. Black, Julian Downward, Ramaswamy Govindan, Roy S. Herbst, John V. Heymach, Elizabeth M. Jaffee, Norbert Kraut, Miriam Merad, Matthew Meyerson, Tej Pandya, Katerina Politi, Arati V. Rao, Charles M. Rudin, Jean Charles Soria, Yuning J. Tang, Kwok-Kin Wong, Timothy A. Yap, Charles Swanton
Read the Full Article.

Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable NSCLC: What This 2026 Meta-Analysis Really Shows
